SCHEMBL10711238

SCHEMBL10711238

O=C1Cc2cc(-c3ccccc3Br)cc(Br)c2N1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 1/20 0.45
▸ CYP11B1 P15538 1/20 0.45
▸ CYP11B2 P19099 1/20 0.45
▸ TDP2 O95551 10/20 0.44
▸ CASP3 P42574 1/20 0.44
▸ CASP7 P55210 1/20 0.44
▸ CASP9 P55211 1/20 0.44
▸ CASP6 P55212 1/20 0.44
▸ CASP8 Q14790 1/20 0.44
▸ MAP3K14 Q99558 1/20 0.44
▸ GRIA1 P42261 1/20 0.43
▸ CACNG8 Q8WXS5 1/20 0.43
▸ KDR P35968 2/20 0.40
▸ GSK3B P49841 2/20 0.40
▸ CDK5 Q00535 2/20 0.40
▸ CHEK1 O14757 1/20 0.40
▸ AURKA O14965 1/20 0.40
▸ DAPK3 O43293 1/20 0.40
▸ PRKD3 O94806 1/20 0.40
▸ MAP4K4 O95819 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10713239 0.87 TDP2 (0.41) TDP2CASP3CASP7CASP9CASP6
SCHEMBL10711958 0.77 TDP2 (0.55) CYP19A1CYP11B1CYP11B2TDP2GRIA1
SCHEMBL10710535 0.76 AHR (0.53) TDP2CASP3CASP7CASP9CASP6
SCHEMBL10714770 0.76 GRIA1 (0.65) TDP2CASP3CASP7CASP9CASP6
SCHEMBL154730 0.74 AHR (0.41) CYP19A1CYP11B1CYP11B2TDP2CASP3
SCHEMBL5373768 0.73 TDP2 (0.49) CYP19A1CYP11B1CYP11B2TDP2CASP3
SCHEMBL837443 0.73 AHR (0.61) CYP19A1CYP11B1CYP11B2TDP2CASP3
SCHEMBL10714240 0.71 TDP2 (0.49) CYP19A1CYP11B1CYP11B2TDP2CASP3
SCHEMBL4410702 0.70 AHR (0.49) CYP19A1CYP11B1CYP11B2TDP2GRIA1
SCHEMBL18210439 0.70 AHR (0.41) CYP19A1CYP11B1CYP11B2TDP2GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4670566-A ANTIIFLAMMATORY AGENTS, ANTICOAGULANTS A. H. ROBINS COMPANY, INCORPORATED (US) 1987-06-02 — — US disclosed
US-4440785-A Methods of using 2-aminobiphenylacetic acids, esters, and metal salts thereof to treat inflammation A. H. ROBINS COMPANY, INC. (US) 1984-04-03 — — US disclosed
Send feedback